Similar articles

• Vasopressor agents for cardiopulmonary resuscitation.

  Cao L, Weil MH, Sun S, Tang W. Cao L, et al. J Cardiovasc Pharmacol Ther. 2003 Jun;8(2):115-21. doi: 10.1177/107424840300800204. J Cardiovasc Pharmacol Ther. 2003. PMID: 12808484 Review.
• Epinephrine for resuscitation from cardiac arrest: A double-edged sword?

  Sutton RM, Berg RA, Helfaer MA. Sutton RM, et al. Crit Care Med. 2009 Apr;37(4):1518-20. doi: 10.1097/CCM.0b013e31819d2e44. Crit Care Med. 2009. PMID: 19318848 No abstract available.
• Adrenergic agonist drug administration during cardiopulmonary resuscitation.

  Lindner KH. Lindner KH. Crit Care Med. 1993 Sep;21(9 Suppl):S324-5. doi: 10.1097/00003246-199309001-00010. Crit Care Med. 1993. PMID: 8103444 Review. No abstract available.
• Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest.

  Koudouna E, Xanthos T, Bassiakou E, Goulas S, Lelovas P, Papadimitriou D, Tsirikos N, Papadimitriou L. Koudouna E, et al. Acta Anaesthesiol Scand. 2007 Sep;51(8):1123-9. doi: 10.1111/j.1399-6576.2007.01383.x. Acta Anaesthesiol Scand. 2007. PMID: 17697310
• Catecholamines in cardiac arrest: role of alpha agonists, beta-adrenergic blockers and high-dose epinephrine.

  Hilwig RW, Kern KB, Berg RA, Sanders AB, Otto CW, Ewy GA. Hilwig RW, et al. Resuscitation. 2000 Oct;47(2):203-8. doi: 10.1016/s0300-9572(00)00261-6. Resuscitation. 2000. PMID: 11008160 No abstract available.